Small cell lung cancer therapeutics market was valued at USD 5.2 billion in 2022 & is expected to grow at a CAGR of 11.2% from 2023-2030...

Lung Cancer Screening Software market was valued at approximately USD 35 Million in 2023 and expected CAGR of around 19% during (2024-2032)....